TherapeuticsMD Inc. (TMDX) experienced a notable surge in its stock price following the release of a strong quarterly report, with shares rising above after-hours highs and reaching the 108 level in pre-market trading. Despite the positive momentum, the stock continues to face very high short interest, with some market participants comparing it to Hims & Hers Health Inc. (HIMS). Year-to-date, TMDX has gained 71%, and investor sentiment on social media platforms is shifting favorably. The stock's movement has posed challenges for short sellers, who had previously driven the price down to 55 earlier in the year. Technical analysis indicates that TMDX has reached the daily volume point of control (VPOC), suggesting a key price level in trading activity.